{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "1,4 substituted piperidinyl NMDA/NR2B antagonists", "item": "https://www.patentleaderboard.com/patent/6476041"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,4 substituted piperidinyl NMDA/NR2B antagonists

1,4 substituted piperidinyl NMDA/NR2B antagonists

US Patent 6476041 · Granted Nov 5, 2002

Estimated economic value: $137,125,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of the menin-MLL interaction2025
Inhibitors of the menin-MLL interaction2023
Dihydropyrrolopyridine inhibitors of ROR-gamma2022
Inhibitors of the menin-MLL interaction2022
Modulators of ROR-gamma2021
Dihydropyrrolopyridine inhibitors of ROR-gamma2021
Inhibitors of the menin-MLL interaction2021
Substituted benzoimidazoles as modulators of ROR-γ2020
Benzimidazole derivatives as modulators of ROR-gamma2020
Dihydropyrrolopyridine inhibitors of ROR-gamma2020
Inhibitors of the menin-MLL interaction2020
Purine derivatives as CD73 inhibitors for the treatment of cancer2020